Continuous Manufacturing Teed Up As Disrupting Force In Pharma Sector
This article was originally published in The Tan Sheet
The question studied over the past decade – whether the industry should adopt continuous manufacturing – has been answered, and the new question is how best to implement it? Pharma firms have drafted a survival guide as they take advantage of continuous manufacturing and realize how it can transform an industry rooted in batch processing.
You may also be interested in...
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.
Draft recommendation offers path to ICH Q12 regulatory relief.
Accelerating post-approval change oversight by focusing on ‘established conditions’ means trusting pharmaceutical quality management systems. But how?